BiotechTube
Home/iWel/Matthew Musho, PhD
MM

Matthew Musho, PhD

VP, Development

iWel

Therapeutic Areas

Metabolic DiseaseDiabetesObesity

iWel Pipeline

DrugIndicationPhase
Wellness/Weight Loss CGMWeight Loss / Wellness MonitoringDevelopment
Prediabetes ManagementPrediabetes Management & PreventionDevelopment
Type 2 Diabetes ManagementType 2 DiabetesDevelopment
Digital TherapeuticsMigraines, Weight Loss, Type 2 DiabetesExploratory
Pet HealthcarePet Diabetes MonitoringExploratory

Leadership Team at iWel

DZ
David Zeng, PhD
President & Chief Technology Officer
GB
Geoffrey Burgess, MD
Chief Medical Officer
RM
Robert Morrow, MS
VP, Software Technology
View full iWel profile